This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Universitéde Strasbourg. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Mohamed Hadjeri
Introduction
Mohamed Hadjeri is an accomplished inventor based in Villefontaine, France. He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds aimed at addressing metabolic syndrome. His work reflects a commitment to advancing medical science through innovative research.
Latest Patents
Hadjeri holds a patent for "Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome." This patent encompasses novel amino-pyrrolinic derivatives, their pharmacologically acceptable salts, and their application in preventing and treating metabolic syndrome. His innovative approach has the potential to impact the treatment landscape for this condition significantly.
Career Highlights
Currently, Mohamed Hadjeri is affiliated with the University of Strasbourg, where he continues to engage in research and development. His academic background and professional experience have equipped him with the skills necessary to contribute meaningfully to his field.
Collaborations
Throughout his career, Hadjeri has collaborated with notable colleagues, including Vincent Gasparik and Hugues Greney. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
In summary, Mohamed Hadjeri is a notable inventor whose work in amino-pyrroline derivatives showcases his dedication to addressing metabolic syndrome. His contributions to pharmacology and collaboration with esteemed colleagues highlight his role in advancing medical research.